Pervasis in the News
Press Kit – PDF with Pervasis corporate profile, Executive Team bios.
Press Contact:
Michele Rozen
Pure Communications, Inc.
Phone: 617-730-8284
Email: michele@purecommunicationsinc.com
2008
August 15-21, 2008
Mass High Tech
“Pervasis Cell-transplant Tech"
May 22, 2008
Science
“Engineering a Healing"
May 4, 2008
MIT news
“MIT researchers find novel way to repair airway injuries”
January 22, 2008
The Regeneration Station
“Pervasis Advances Tissue Engineered Products for Vascular Health”
January 16, 2008
Medical Device Daily
“Financing Roundup”
January 15, 2008
The Boston Globe
“Pervasis secures additional funding”
January 15, 2008
Boston Business Journal
“Pervasis Therapeutics closes on $9.75M funding round”
January 15, 2008
Mass High Tech
“Pervasis to pump up blood vessel repair rech with $10M round”
January 15, 2008
TheDeal.com
“VC Dealflow”
January 15, 2008
Venture Beat
“Pervasis Therapeutics pulls in $9.8M for regenerative medicine”
January 15, 2008
BioWorld Today
“Pervasis Gets $9.75M to Boost Blood Vessel Repair Candidate”
January 15, 2008
Xconomy
“Pervasis Picks Up $9.75M”
2007
September 17, 2007
BioWorld Today
“Other News to Note”
September 1, 2007
Genetic Engineering News
“Clinical Trials – September”
August 27, 2007
Clinical Trials Week - Bioengineering
“Pervasis Therapeutics Successfully Completes Enrollment for Vascugel Phase II Clinical Trials”
August 16, 2007
FDA News
“Pervasis Therapeutics Successfully Completes Enrollment for Vascugel Trials”
June 26, 2007
Technology Review
“Healing Blood Vessels”
May 15, 2007
Red Herring
“Top 100 Winner – North America 2007”
March 29, 2007
BioCentury
“Clinic Results” (Subscription Only)
March 20, 2007
Boston Business Journal
“Pervasis Starts Phase II Trials on Vascular Drug”
March 20, 2007
BioWorld Today
“Clinic Results” (Subscription Only)
March 19, 2007
Pharma Company Insight
“Pervasis launches enrollment for two Phase II Vascugel trials”
(Subscription Only)
March 19, 2007
Pharmaceutical Business Review
“Pervasis Begins Phase II Trials for Vascular Therapeutic”
January 2007
Biomedical Materials
“TISSUE ENGINEERING - Pervasis is set to go ahead with Phase II trials of cell-based repair gel, following good results from initial trials”
[ back to top ]
2006
November 24, 2006
Cardiovascular Device Update
“Alternative materials offer surprising new options vs. stenting”
(Subscription Only)
November 20, 2006
FDANews Drug Pipeline Alert
“Pervasis Announces Results of Cell Therapy Safety Trials”
November 16, 2006
BioWorldToday
“Clinical Trial Roundup”
(Subscription Only)
November 16, 2006
Pharma Company Insight/Pharmaceuticals (UK)
“Pervasis reports successful Phase I safety results for Vascugel” (Subscription Only)
November 15, 2006
United Press International (UPI)
“Pervasis testing vascular repair gel”
November 1, 2006
Biomedical Materials
“Tissue engineering: Phase 1 trials begin of first biologically-active treatment to ameliorate acute vascular injury”
November 2006
Cardiovascular Innovations
“Cellular ‘wrap’ may
help regenerate damaged
vessels”
October 20, 2006
MassHighTech
“Cell Culture”
October 19, 2006
Biotech Week
“Pervasis Therapeutics' Vascugel initiates U.S. clinical Trials”
October 2, 2006
The Boston Globe
“Cells, Not Tools, May Help Fix Arteries” [ PDF ]
October 2, 2006
BioCentury
“News Roundup” (Subscription Only)
September 28, 2006
BioWorldToday
“Clinical News” (Subscription Only)
September 28, 2006
Medical Industry Week/Medical Devices (UK)
“Pervasis Starts Enrolling Patients in Clnical Trial of ESRD Therapy” (Subscription Only)
[ back to top ]
|
